MedTrace Logo

AMENDTM Mitral Valve Repair System, Annuloplasty Ring Applied in a Transcatheter Method

NCT02602613 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2019-05-03

No results posted yet for this study

Summary

A multi center study to evaluate the safety of the AMENDTM Mitral Valve Repair System and its ability to reduce mitral regurgitation. AMEND device is an annuloplasty ring implanted in a minimally invasive trans-catheter method.

Conditions

  • Mitral Regurgitation

Interventions

DEVICE

AMEND Mitral Valve Repair System

Annuloplasty ring applied in a transcatheter method

Sponsors & Collaborators

  • Valcare Medical Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Belgium
  • Czechia
  • Israel
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02602613 on ClinicalTrials.gov